• In November 2024, SonoMotion received FDA de novo clearance for its Stone Clear ultrasound device, enabling non‑invasive passage of post‑lithotripsy kidney fragments in awake patients.

• In April 2024, Johnson & Johnson finalized a 13.1 billion acquisition of Shockwave Medical, integrating its intravascular lithotripsy tech to treat calcified arterial lesions.

In this report, the Lithotripsy Devices Market has been segmented by Product, Application, End Users and Geography.

Lithotripsy Devices Market, Segmentation by Product

The Lithotripsy Devices Market has been segmented by Product into Extracorporeal Shock Wave Lithotripsy Devices and Intracorporeal Lithotripsy Devices - Laser Lithotripsy Devices, Electrohydraulic Lithotripsy Devices, Ultrasonic Lithotripsy Devices, and Mechanical Lithotripsy Devices.

Extracorporeal Shock Wave Lithotripsy Devices (ESWL)

ESWL devices dominate the lithotripsy devices market, accounting for approximately 60% of total revenue. These non-invasive devices use shock waves to break down kidney stones and are preferred for their minimal recovery time and lower risk of complications.

Intracorporeal Lithotripsy Devices

Intracorporeal lithotripsy devices represent about 40% of the market, encompassing several subtypes based on energy source:

Laser Lithotripsy Devices: Approximate market share: 15%. These use laser energy to precisely fragment urinary stones, offering high efficacy and versatility in different clinical scenarios. Electrohydraulic Lithotripsy Devices: Approximate market share: 10%. Utilizing electrical sparks to generate shock waves, they are effective for hard stone types but are being replaced by newer technologies. Ultrasonic Lithotripsy Devices: Approximate market share: 10%. These use ultrasonic vibrations to break up stones and are often used in combination with aspiration systems for stone removal. Mechanical Lithotripsy Devices: Approximate market share: 5%. These use mechanical force to crush stones and are primarily used in endoscopic procedures for biliary and pancreatic duct stones.

Lithotripsy Devices Market, Segmentation by Application

The Lithotripsy Devices Market has been segmented by Application into Kidney Stones , Ureteral Stones , Pancreatic Stones and Bile Duct Stones.

Kidney Stones

Kidney stones account for approximately 50% of the lithotripsy devices market, driven by the high prevalence of nephrolithiasis and the growing adoption of non-invasive treatment methods such as extracorporeal shock wave lithotripsy (ESWL).

Ureteral Stones

Ureteral stones represent about 25% of total revenue, with intracorporeal lithotripsy devices such as laser and ultrasonic systems widely used for effective stone fragmentation and minimally invasive removal.

Pancreatic Stones

Pancreatic stones contribute nearly 15% of the market, treated with specialized intracorporeal devices and mechanical lithotripsy systems in endoscopic procedures aimed at improving pancreatic duct drainage.

Bile Duct Stones

Bile duct stones account for about 10% of total revenue, with mechanical and electrohydraulic lithotripsy systems used to facilitate stone clearance and endoscopic removal in complex cases.

Lithotripsy Devices Market, Segmentation by End Users

The Lithotripsy Devices Market has been segmented by End Users into Hospitals , Ambulatory Surgical Centers and Other End Users.

Hospitals

Hospitals are the primary end users in the lithotripsy devices market, holding a significant 45.7% share of the revenue in 2022. Their dominance is attributed to comprehensive infrastructure, including advanced imaging technologies and skilled medical personnel, facilitating effective utilization of lithotripsy procedures. The availability of a wide range of lithotripsy devices in hospital settings ensures optimal patient care and outcomes. Furthermore, hospitals often serve as referral centers for complex cases, reinforcing their central role in the lithotripsy devices market.

Ambulatory Surgical Centers

Ambulatory Surgical Centers (ASCs) are emerging as significant contributors to the lithotripsy devices market, accounting for approximately 35% of the global revenue share in 2022. This growth is driven by the increasing demand for cost-effective and minimally invasive procedures. ASCs offer streamlined services with reduced hospital stays, appealing to patients seeking efficient treatment options. Their specialization in specific medical fields, such as urology, allows for focused expertise in lithotripsy procedures, enhancing patient satisfaction and outcomes.

Other End Users

The "Other End Users" category, encompassing clinics, specialty centers, and research institutions, contributes to around 19.3% of the lithotripsy devices market revenue in 2022. These facilities play a vital role by providing accessible treatment options in regions where hospitals and ASCs may be limited. Their involvement in clinical research and trials fosters innovation and the development of advanced lithotripsy technologies. While their market share is comparatively smaller, their impact on expanding the reach and capabilities of lithotripsy treatments is significant.

Lithotripsy Devices Market, Segmentation by Geography

In this report, the Lithotripsy Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Lithotripsy Devices Market Share (%), by Geographical Region

North America

North America holds the largest share of the lithotripsy devices market, accounting for approximately 38% of revenue in 2022. This dominance is driven by advanced healthcare infrastructure, widespread adoption of minimally invasive treatments, and a high prevalence of kidney stone cases. Robust R&D investments and a favorable regulatory environment further strengthen the market position of North America.

Europe

Europe represents a significant portion of the lithotripsy devices market, contributing to around 28% of the total revenue. Factors such as technological advancements, increasing incidence of urolithiasis, and the presence of prominent market players fuel market growth in this region. Strong healthcare systems and rising awareness of non-invasive procedures support continued adoption.

Asia Pacific

Asia Pacific is witnessing rapid growth in the lithotripsy devices market, with an estimated market share of approximately 22% in 2022. The rising geriatric population, growing healthcare expenditure, and increasing prevalence of urinary tract diseases contribute to this upward trajectory. Emerging economies such as China and India present significant growth opportunities due to improving healthcare access and increasing awareness of lithotripsy treatments.

Middle East and Africa

The Middle East and Africa region holds a smaller yet noteworthy share of the lithotripsy devices market, contributing around 7% of the revenue. Growth in this region is primarily driven by expanding healthcare infrastructure and a rising number of kidney stone cases. Increased government initiatives and partnerships with players are expected to bolster market expansion in the coming years.

Latin America

Latin America accounts for an estimated 5% of the lithotripsy devices market revenue, driven by growing awareness and improving access to healthcare services. Factors such as the rising prevalence of lifestyle diseases, increasing healthcare investments, and expanding medical tourism contribute to the market's steady growth in this region.

This report provides an in depth analysis of various factors that impact the dynamics of Lithotripsy Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Technological advancements in lithotripsy
• Rising prevalence of kidney stones
• Increasing demand for minimally invasive procedures

• Expanded applications in urology - The increasing integration of advanced diagnostic and therapeutic tools in urology is significantly propelling market growth. These innovations improve precision, reduce treatment time, and enhance patient outcomes across various urological disorders. As a result, healthcare providers are more inclined to adopt next-generation solutions, especially in minimally invasive surgeries.

  Technological breakthroughs have expanded the use of medical devices in prostate cancer, kidney stones, urinary incontinence, and bladder issues. These applications go beyond traditional practices, offering new opportunities for clinical research and commercialization. The versatility of these devices allows clinicians to diagnose and treat conditions with higher success, thus increasing their adoption.

  Growing urological disease prevalence, especially among the aging population, also supports this expansion. Patients seek quicker recovery, and technologies like laser therapy and robotic surgeries meet those demands. The improved outcomes drive confidence in device-based procedures, further amplifying demand.

  The expansion into pediatric and female urology represents an emerging frontier. These new applications are not only improving care delivery but also broadening the commercial scope for manufacturers. As a result, the industry is witnessing a robust surge in urology-specific device development across both diagnostics and therapeutics.

Restraints

• High cost of lithotripsy devices
• Lack of skilled professionals
• Adverse effects associated with lithotripsy

• Limited accessibility in rural areas - Despite advancements, the market faces a major challenge in the form of limited accessibility in rural areas. Many remote regions lack the infrastructure and trained professionals needed to deliver advanced care. As a result, patients in these areas experience delayed treatment and limited exposure to cutting-edge medical devices.

  The disparity in technology availability is more pronounced in developing and low-income regions. Even when such devices exist, the lack of training and technical expertise often restrict their use. Moreover, the cost of installation and support makes them unviable for rural clinics.

  This access gap leads to missed diagnoses and poorer health outcomes, particularly for chronic urological conditions. Patients must travel long distances, facing additional financial and logistical challenges. This ultimately discourages timely intervention and lowers the adoption rate of modern technologies.

  To bridge this gap, there is a need for government funding, public-private partnerships, and the rollout of telemedicine solutions. Until such support is universally established, market penetration in rural zones will remain a significant challenge for the medical technology industry.

Opportunities

• Emerging markets in Asia-Pacific
• Development of portable lithotripsy devices
• Collaborations for research and development

• Focus on patient-centric technologies -The market is rapidly shifting toward patient-centric technologies that prioritize comfort, usability, and improved treatment experience. New designs focus on portability and personalization, allowing for better compliance and enhanced care. This movement aligns with the demand for value-based healthcare, where outcomes and satisfaction are emphasized over volume.

  Technological innovation has enabled wearable monitors, remote diagnostics, and AI-integrated platforms that allow patients to take charge of their health. These advancements enable early detection, continuous tracking, and real-time alerts that facilitate proactive care.

  Manufacturers are also focusing on designing for diverse patient needs, including age, mobility limitations, and chronic illness. This approach improves treatment adherence and boosts overall patient satisfaction. The shift in design philosophy toward user experience ensures higher engagement and clinical efficiency.

  The integration of digital health ecosystems supports remote consultations, data-driven treatment adjustments, and home-based care. These systems are transforming how care is delivered, reducing hospital strain, and opening up new business opportunities for tech-enabled medical solutions.

Key players in Lithotripsy Devices Market include:

• Siemens AG
• Storz Medical AG
• Boston Scientific
• Olympus
• Richard Wolf
• Direxgroup
• Novamedtek
• Dornier Medtech
• Medispec
• Walz Elektronik

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Market Share Analysis
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis